Gene30833
NT5C: 5', 3'-nucleotidase, cytosolic
13 sourcesgene-search-2026-11-13-0.2.1
Cite this record
ConductScience Library. NT5C: 5', 3'-nucleotidase, cytosolic. Genes, record 30833. Release gene-search-2026-11-13-0.2.1, 13 Nov 2026. https://conductscience.org/library/genes/30833
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q8TCD5 | 5'(3')-deoxyribonucleotidase, cytosolic type | 201 | 4 | Ensembl, GeneID, HGNC |
Source UniProt
Patents37
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 35732 | Q8TCD5 | Espacenet |
| JP 2025062604 A | 2025-04-14 | 331 | Q8TCD5 | Espacenet |
| US 20240398993 A1 | 2024-12-05 | 29754 | Q8TCD5 | Espacenet |
| US 20240327476 A1 | 2024-10-03 | 35732 | Q8TCD5 | Espacenet |
| US 20240285795 A1 | 2024-08-29 | 180908 | Q8TCD5 | Espacenet |
| US 20230026259 A1 | 2023-01-26 | 331 | Q8TCD5 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 331 | Q8TCD5 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 331 | Q8TCD5 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 103302 | Q8TCD5 | Espacenet |
| US 20210115101 A1 | 2021-04-22 | 35732 | Q8TCD5 | Espacenet |
NIH grants476
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | NT5C papers | Newest fiscal year |
|---|---|---|---|
| ZIAAI000732 | Clinical, Immunological and Genetic Analyses of ALPS and Related Immunedysregulatory Disorders | 5 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 4 | 2025 |
| P30CA006973 | Regional Oncology Research Center | 2 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 2 | 2025 |
| P30CA016056 | Roswell Park Cancer Center Support Grant | 2 | 2025 |
| R37AI018045 | Coordinate Regulation of Virulence in Vibrio Cholerae | 2 | 2025 |
| D43TW012030 | Training Africans to Lead and Execute Neurological Trials & Studies (TALENTS) | 1 | 2025 |
| F32GM153031 | Precision Deaminases to Expand the Scope of Diseases Amenable to CRISPR-mediated Correction | 1 | 2025 |
| K08CA256045 | Enhancing the efficacy of Radiation Therapy for brainstem glioma by targeting ATM | 1 | 2025 |
| P01AI063302 | The intersection of innate and adaptive immunity to intracellular pathogens | 1 | 2025 |
Source NIH's project files
Papers612
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Convergent evolution of viral nucleases targeting cyclic dinucleotides. | PLoS Pathog | 2026 | 42743306 | PubTator, text mining | PubMed |
| Proximity Proteomics Maps Candidate Cellular Uptake Pathways for Cell-Derived Nanovesicles. | Small Methods | 2026 | 42687504 | PubTator, text mining | PubMed |
| SLECA: A Single-Cell Atlas of Systemic Lupus Erythematosus Enabling Rare-Cell Discovery Using Graph Transformer. | Comput Struct Biotechnol J | 2026 | 42445523 | PubTator, text mining | PubMed |
| Characterization of a transmembrane-activating STING agonist using genetically humanized mice. | Cell Rep | 2026 | 42228573 | PubTator, text mining | PubMed |
| The causal effect of matrix metalloproteinase 9 on interstitial lung disease risk mediated by effector memory double negative T cells: A mediation Mendelian randomization study. | Medicine (Baltimore) | 2026 | 41995530 | PubTator, text mining | PubMed |
| Integrated transcriptomic and metabolomic analysis identifies C5NT1AL as a candidate gene influencing inosine monophosphate levels in chicken breast muscle. | Poult Sci | 2026 | 41905064 | PubTator, text mining | PubMed |
| Snapshot on Cell-to-Cell Communication Nanotubes: From Bacteria to Humans. | Biology (Basel) | 2026 | 41892274 | PubTator, text mining | PubMed |
| DNA-PK interacts with cyclic dinucleotides and inhibits type I interferon responses. | J Exp Med | 2026 | 41874365 | PubTator, text mining | PubMed |
| Peripheral Lymphocyte Dynamics in the Immune Microenvironment of Multiple Myeloma During Autologous Stem Cell Transplantation. | Cureus | 2026 | 41798467 | PubTator, text mining | PubMed |
| A STING-activating biomimetic mineralized nanovaccine triggers robust anti-tumor immunity. | Cancer Immunol Immunother | 2026 | 41793474 | PubTator, text mining | PubMed |
None in this release
- Drugs
- Trials
Sources 13
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
- USPTO's sequence listingsPublic domain in the US. Source: United States Patent and Trademark Office, www.uspto.gov
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
- USPTO's sequence listingsUSPTO's sequence listings of patents and published applications, from its bulk data files. No license named for the files. USPTO's terms say "most government-produced materials appearing on this website are not subject to copyright restrictions within the United States and are therefore in the public domain", and ask that USPTO be given appropriate acknowledgement ("Source: United States Patent and Trademark Office, www.uspto.gov"). USPTO does not endorse ConductScience or this release. Read on 12 Nov 2026 at https://www.uspto.gov/terms-use-uspto-websites
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
Source: United States Patent and Trademark Office, www.uspto.gov. USPTO does not endorse ConductScience or this database.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/30833
GET https://conductscience.org/api/genes/v1/30833/patents?page=2